SCHEMBL3761701

SCHEMBL3761701

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3cccc(NS(=O)(=O)Cc4ccccc4)c3)c2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
BRD4 O60885 3/20 0.41
PIK3CA P42336 4/20 0.38
PIK3CD O00329 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
LMNA P02545 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
BUB1 O43683 1/20 0.37
USP2 O75604 1/20 0.36
MAPK1 P28482 1/20 0.36
HIF1A Q16665 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3761651 0.91 ALDH1A1 (0.48) TP53ALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL3756222 0.91 BRD4 (0.44) TP53BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3760624 0.87 THRB (0.45) TP53ALDH1A1HSD17B10BRD4LMNA
SCHEMBL3758789 0.85 SMN1; SMN2 (0.46) ALDH1A1HPGDSMN1; SMN2PIK3CDPIK3CB
SCHEMBL3758948 0.83 PIK3CD (0.42) ALDH1A1HPGDHSD17B10BRD4PIK3CA
SCHEMBL3765924 0.83 PIK3CA (0.44) ALDH1A1HPGDHSD17B10BRD4PIK3CA
SCHEMBL3759350 0.82 NPC1 (0.51) ALDH1A1SMN1; SMN2PIK3CA
SCHEMBL3754652 0.82 PIK3CA (0.40) ALDH1A1HPGDSMN1; SMN2HSD17B10BRD4
SCHEMBL3760075 0.81 PRKDC (0.42) HSD17B10BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3766528 0.81 PRKDC (0.52) ALDH1A1PIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA TP53 895/4885ALDH1A1 3061/4885HPGD 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.